Plexision Aims to Deliver Single-Day Results for Organ Transplant Rejection Testing With Antigen Dx
NEW YORK— Diagnostics startup Plexision aims to cut down delays in testing for organ transplant rejection with an antigen-based blood test for early signs a patient's immune system is attacking the donated tissue.